Can fite biopharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Can fite biopharma Contact Number

CanFite BioPharma Crunchbase Company Profile & …

7 hours ago Crunchbase.com Show details

Company Type For Profit. Contact Email [email protected] Phone Number +97239241114. Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical

Founded: 1994
Founder: Pnina Fishman

Category: Contact NumberShow more

Phone: 972 3 924 1114 http://www.canfite.com Company

Just Now Content.equisolve.net Show details

including anti-inflammatory effects and reduced liver fat content. Can-Fite is now preparing a Phase IIb study in NASH, with manufacturing of the drug supply complete. NASH is an unmet medical need projected to become a $35-$40 billion market by 2025. Investor Contact: Motti Farbstein, CFO, + 972 3 924 1114

Category: Phone NumberShow more

CanFite BioPharm (NYSE American: CANF)

4 hours ago Canfinfo.com Show details

Can-Fite Biopharma (CANF) is a client of RedChip Companies, Inc. CANF agreed to pay RedChip Companies, Inc. a cash fee of $5,000 monthly, beginning in August 2019, and 16,500 shares of CANF Rule 144 stock for 6 months of RedChip investor awareness services and consulting services.

Category: Contact NumberShow more

(Commission File Number) CANFITE BIOPHARMA LTD.

4 hours ago Can-fite.com Show details

(Commission File Number) CAN-FITE BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) 10 Bareket Street Kiryat Matalon, P.O. Box 7537 Petach-Tikva 4951778, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Category: Contact NumberShow more

FORM D SEC

4 hours ago Sec.gov Show details

Can-Fite BioPharma Ltd. Street Address 1 Street Address 2; 10 BAREKET STREET, KIRYAT MATALON: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; PETACH TIKVA: ISRAEL: 4951778: 972 39241114

Category: Contact NumberShow more

Www.sec.gov

4 hours ago Sec.gov Show details

CAN-FITE BIOPHARMA LTD. Warrant No.: 2021 - __ Initial Exercise Date: August 16, 2021 : DTC Participant name and number: _____ Contact of DTC Participant: _____ Telephone Number of Participant Contact: _____ (4) Accredited Investor. If the Warrant is being exercised via cash exercise, the undersigned is an “accredited investor” as

Category: Contact NumberShow more

CanFite BioPharma Force

Just Now Forcewealth.com Show details

021-02-22

Contact; Can-Fite BioPharma admin 2021-02-22T14:31:08-05:00. Can-Fite BioPharma Muscles Don’t Get Cancer. estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking

Category: Contact NumberShow more

CANFITE BIOPHARMA LTD.

9 hours ago Canfite.com Show details

(Commission File Number) CAN-FITE BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) 10 Bareket Street Kiryat Matalon, P.O. Box 7537 Petach-Tikva 4951778, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Category: Contact NumberShow more

CANFITE BIOPHARMA LTD.

6 hours ago Canfite.com Show details

(Commission File Number) € CAN-FITE BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) € 10 Bareket Street Kiryat Matalon, P.O. Box 7537 Petach-Tikva 4951778, Israel (Address of principal executive offices) € Indicate by check mark whether the registrant files or will file annual reports under cover Form€20-F or Form

Category: Contact NumberShow more

CanFite BioPharma Ltd. (Form: 6K, Received: 08/16/2021

6 hours ago Content.edgar-online.com Show details

(Commission File Number) CAN-FITE BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) 10 Bareket Street. Kiryat Matalon, P.O. Box 7537. Petach-Tikva 4951778, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Category: Contact NumberShow more

CanFite Biopharma Ltd Sponsore (CANF) Company Profile

4 hours ago Finance.yahoo.com Show details

See the company profile for Can-Fite Biopharma Ltd Sponsore (CANF) including business summary, industry/sector information, number of employees, business summary, corporate governance, key

Category: Contact NumberShow more

CanFite Biopharma Ltd (CANF) Market Cap Zacks.com

1 hours ago Zacks.com Show details

As of the previous market close, CanFite Biopharma Ltd has a market cap of $31.69M, which represents its share price of $1.66 multiplied by its outstanding shares number

Category: Contact NumberShow more

Can Fite BioPharma : Fact Sheet MarketScreener

Just Now Marketscreener.com Show details

Can-Fite BioPharma Ltd. 10 Bareket Street Kiryat Matalon Petah Tikva, 4951778, Israel October 13, 2021

Category: Contact NumberShow more

CAN FITE BIOPHARMA (CANF.TA) Company Profile & Facts

8 hours ago Finance.yahoo.com Show details

See the company profile for CAN FITE BIOPHARMA (CANF.TA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Contact NumberShow more

CanFite Biopharma Number of Employees 20122021 CANF

5 hours ago Macrotrends.net Show details

Can-Fite Biopharma number of employees from 2012 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Can Fite Biopharma Ltd. is a …

Category: Contact NumberShow more

CanFite BioPharma Ltd. (Form: 6K, Received: 04/23/2021

3 hours ago Content.edgar-online.com Show details

(Commission File Number) CAN-FITE BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) 10 Bareket Street. Kiryat Matalon, P.O. Box 7537. Petach-Tikva 4951778, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Category: Contact NumberShow more

Canfite Biopharma Ltd. (CANF) 10K Annual Reports & 10Q SEC

6 hours ago Last10k.com Show details

View differences made from one year to another to evaluate Canfite Biopharma Ltd.'s financial trajectory Sample 10-K Year-over-Year (YoY) Comparison Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Canfite Biopharma Ltd..

Category: Contact NumberShow more

Cardioxyl Pharmaceuticals VentureRadar

3 hours ago Ventureradar.com Show details

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19. The Company's lead drug candidate, Piclidenoson, is currently in a Phase III

Category: Contact NumberShow more

CANF CanFite Biopharma Ltd. ADR Stock Price & News WSJ

3 hours ago Wsj.com Show details

View the latest Can-Fite Biopharma Ltd. ADR (CANF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Category: Contact NumberShow more

Can Fite BioPharma : Fact Sheet MarketScreener

9 hours ago Marketscreener.com Show details

Can-Fite BioPharma Ltd. 10 Bareket Street Kiryat Matalon Petah Tikva, 4951778, Israel September 30, 2021

Category: Contact NumberShow more

CanFite BioPharma Ltd. (CANF) Company Profile & Overview

6 hours ago Stockanalysis.com Show details

The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah-Tikva, Israel.

Category: Contact NumberShow more

CanFite Biopharma Ltd ADR (CANF) Recent Earnings

8 hours ago Earningswhispers.com Show details

Can-Fite Biopharma Ltd ADR (CANF) reported a 2nd Quarter June 2021 loss of $0.19 per share on revenue of $0.3 million. The consensus estimate was a loss of $0.12 per share on revenue of $0.1 million. Revenue grew 22.5% on a year-over-year basis. Can Fite Biofarma Ltd is a clinical stage drug development company.

Category: Contact NumberShow more

Overview CanFite BioPharma

5 hours ago Can-fite.com Show details

Overview. Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase II and III clinical development stage, which address inflammatory, liver and metabolic diseases.

Category: Contact NumberShow more

CANF CanFite Biopharma Ltd. Stock Price & News WSJ

1 hours ago Wsj.com Show details

News Can-Fite Biopharma Ltd.CANF. No news for CANF in the past two years. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated …

Category: Contact NumberShow more

How Do Analysts Feel About CanFite BioPharma Ltd. (CANF

1 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 17.19 million. CANF does have institutional investors; and they hold 12.40% of the stock. Can-Fite BioPharma Ltd. – Insider Activity and Holdings. Currently, the stock has been recommended as Moderate Buy by 2 of the brokerage firms.

Category: Contact NumberShow more

CEO.CA #canf CanFite BioPharma Ltd. (CANF)

9 hours ago Chat-beta.ceo.ca Show details

Real-time discussion about Can-Fite BioPharma Ltd. (CANF) on CEO.CA, an investment chat community for Canada's small cap markets

Category: Contact NumberShow more

CanFite BioPharma Ltd. CANF:NYSE.MKT

9 hours ago Thelifesciencesreport.com Show details

Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with a platform technology that addresses multibillion dollar markets in the treatment of cancer, inflammatory and other diseases. The completed its Phase 2/3 trials for psoriasis and is in Phase 2 trials for liver cancer.

Category: Contact NumberShow more

What is Current CanFite Biopharma (NYSEMKT:CANF) Stock

1 hours ago Macroaxis.com Show details

On a scale of 0 to 100, Can-Fite Biopharma holds a performance score of 0. Can-Fite Biopharma performance is based on evaluating its risk-adjusted returns. Stock performance charts for Can-Fite Biopharma

Category: Contact NumberShow more

How to buy CanFite BioPharma stock (NYSE MKT: CANF

1 hours ago Finder.com Show details

Over the last 12 months, Can-Fite BioPharma's shares have ranged in value from as little as $1.51 up to $3.07. A popular way to gauge a stock's volatility is its "beta". Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Can-Fite BioPharma's is 1.534.

Category: Contact NumberShow more

CanFite BioPharma (CANF): FDA, EMA Approve Drug Firm's

2 hours ago Investorshub.advfn.com Show details

Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report® Business Wire - 5/27/2021 6:00:00 AM: Can-Fite to Present at Benzinga’s Global Small Cap Conference on May 13, 2021 Business Wire - 5/6/2021 7:00:00 AM

Category: Contact NumberShow more

CAN FITE Number of Employees vs Beta CANF.TA

3 hours ago Cdn-macroaxis.netdna-ssl.com Show details

For CAN FITE profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CAN FITE to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CAN FITE BIOPHARMA utilizes its assets to generate profit and value for its shareholders.

Category: Contact NumberShow more

Should You Expect A Quick Recovery From CanFite BioPharma

5 hours ago Marketingsentinel.com Show details

Can-Fite BioPharma Ltd. (AMEX:CANF)’s traded shares stood at 0.3 million during the last session. At the close of trading, the stock’s price was $1.49, to imply a decrease of -2.61% or -$0.04 in intraday trading. The CANF share’s 52-week high remains $4.39, putting it -194.63% down since that

Category: Contact NumberShow more

CanFite BioPharma Ltd (CANF) Price Targets From Analysts

6 hours ago Stocknews.com Show details

Can-Fite BioPharma Ltd's upside potential (average analyst target price relative to current price) is greater than 88.77% of all US stocks. Can-Fite BioPharma Ltd's number of analysts covering the stock is greater than 13.25% of Healthcare stocks.

Category: Contact NumberShow more

CanFite Biopharma Ltd Sponsore (CANF) company profile

4 hours ago Uk.finance.yahoo.com Show details

See the company profile for Can-Fite Biopharma Ltd Sponsore (CANF), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information.

Category: Contact NumberShow more

CanFite Biopharma Ltd (CANF) Stock Guide Finny

1 hours ago Askfinny.com Show details

You'll get all this info in one place. Or you can just type "CANF news" to get the latest stock news. Looking to buy or sell Can-Fite Biopharma Ltd (CANF)? Interested in getting the full scoop on CANF, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

Category: Contact NumberShow more

CANF Stock quote for CanFite Biopharma Ltd MSN Money

3 hours ago Msn.com Show details

Can-Fite BioPharma Ltd. (AMEX: CANF) Up Almost 6.28% In One Month, Long Term Looking Good. marketingsentinel 6 days ago. Can-Fite BioPharma looks forward to completing enrollment of its Phase IIl

Category: Contact NumberShow more

Israeli Biopharma Advances Five Drug Candidate Trials in Q2/21

Just Now Streetwisereports.com Show details

In terms of finances, Can-Fite spent $3 million ($3M) during Q2/21 and ended the quarter with $7.5M. Subsequently, in August, the company held a $10M offering. Dawson James has a Buy rating and a $5 per share target price on Can-Fite BioPharma, the shares of which are currently trading at about $1.87 apiece. [NLINSERT} Disclosures:

Category: Contact NumberShow more

Biopharma Begins Phase 2 COVID Clinical Trial

3 hours ago Streetwisereports.com Show details

In a March 5 research note, Dawson James Securities analyst Jason Kolbert reported that Can-Fite BioPharma Ltd. (CANF:NASDAQ) has begun its Phase 2 trial of Piclidenoson in hospitalized patients with mild to moderate COVID. In this study, the Israel-based biopharma a total of 40 patients are randomized on a 1:1 basis to receive either

Category: Contact NumberShow more

CanFite BioPharma, Ltd.Company Report

5 hours ago Slideshare.net Show details

Can-Fite BioPharma, Ltd.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biome…

Category: Contact NumberShow more

Amended Statement of Ownership (sc 13g/a)

2 hours ago Ih.advfn.com Show details

Can-Fite BioPharma Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.25 per share (Title of Class of Securities) 13471N201** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ý: Rule 13d-1(b) ¨ Rule 13d-1(c

Category: Contact NumberShow more

Is CanFite Stock a good investment? CANF Macroaxis

5 hours ago Macroaxis.com Show details

Can-Fite Biopharma is trading at 1.49 as of the 11th of October 2021, a -1.32 percent down since the beginning of the trading day. The stock's lowest day price was 1.49. Get the latest Can-Fite Biopharma detailed stock quotes, stock trade data, stock price info, and performance analysis, including Can-Fite Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

Is CAN FITE BIOPHARMA ADR REP 30 ORD (CANF) A Winner in

7 hours ago Investorsobserver.com Show details

CAN FITE BIOPHARMA ADR REP 30 ORD is near the top in its sector according to InvestorsObserver. CANF gets an overall rating of 69. That means it scores higher than 69% of stocks. CAN FITE BIOPHARMA ADR REP 30 ORD gets a 81 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

Category: Contact NumberShow more

CTI BioPharma Number of Employees 20062021 CTIC

Just Now Macrotrends.net Show details

CTI BioPharma number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. CTI BioPharma Corp. is a …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Costco
Cisco
Ccu
Cae